BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, December 16, 2025
See today's BioWorld
Home
» Other news to note for Dec. 1, 2021
To read the full article
sign up for free
or
sign in
.
Other news to note for Dec. 1, 2021
Dec. 1, 2021
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Cellevolve, Epivax, Eurocrine, Everest, Gensight, Greenlight, IFM, Immunome, Inmune, Janssen, Novartis, Noxopharm, Oragenics, Oravax, Origimm, Orion, Premas, Providence, Samus, Sanofi, Suono, Tempus, Trefoil, Verndari, Zymeworks.
BioWorld
Briefs
Other news to note
Coronavirus